Back to Agenda
Precision Medicine and Personalised Healthcare
Session Chair(s)
Marisa Papaluca-Amati, MD
Marisa Papaluca-Amati, Scientific Committees Regulatory Science Strategy, Europe, European Medicines Agency, Netherlands
Disease modifying therapies allow to look at the trajectory of disease combining in silico and real world clinical data. This session will review progress towards prevention and personalised medicine combining biological plausible advances in scientific methods and their application within healthcare systems.
Speaker(s)
Elmar Nimmesgern
Innovative and Personalised Medicine Unit , European Commission, Belgium
Panel Discussion
Virginia Acha, PHD, MSC
Global Lead, Global Regulatory Policy, Merck & Co., Inc., United States
Panel Discussion
Bettina Ryll
Member of the First EU Cancer Mission Board, MPNE, Vision Zero Cancer, Sweden
Panel Discussion
Donald Singer, MD, FRCP
Executive Committee, EACPT, United Kingdom
Panel Discussion
Have an account?